Organon & Co (OGN)
20.37
-0.03
(-0.15%)
USD |
NYSE |
May 08, 16:00
20.29
-0.08
(-0.39%)
Pre-Market: 20:00
Organon Profit Margin (Quarterly): 12.39% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 12.39% |
| December 31, 2023 | 34.17% |
| September 30, 2023 | 3.82% |
| June 30, 2023 | 15.05% |
| March 31, 2023 | 11.51% |
| December 31, 2022 | 7.27% |
| September 30, 2022 | 14.77% |
| June 30, 2022 | 14.76% |
| March 31, 2022 | 22.21% |
| Date | Value |
|---|---|
| December 31, 2021 | 12.60% |
| September 30, 2021 | 20.19% |
| June 30, 2021 | 26.77% |
| March 31, 2021 | 26.49% |
| December 31, 2020 | 22.81% |
| September 30, 2020 | 33.91% |
| June 30, 2020 | 35.52% |
| March 31, 2020 | 39.49% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
3.82%
Minimum
Sep 2023
39.49%
Maximum
Mar 2020
20.81%
Average
20.19%
Median
Sep 2021
Profit Margin (Quarterly) Benchmarks
| Amgen Inc | -1.52% |
| Merck & Co Inc | 30.19% |
| Pfizer Inc | 20.94% |
| Alnylam Pharmaceuticals Inc | -13.34% |
| Moderna Inc | -703.6% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 9.23% |
| Return on Invested Capital | 12.56% |
| Gross Profit Margin (Quarterly) | 59.00% |
| Operating Margin (Quarterly) | 25.52% |
| Return on Net Operating Assets | 11.43% |